Tuesday, July 20, 2021 10:17:19 PM
PBIO is no stranger to granting exclusive rights. They did it with their prior technologies in countries all over the world. All listed in their 10-k.
I have a feeling that Morrison may have secured rights during their merger negotiations. Whether a joint venture or percentage sharing.
PBIO is in heavy, heavy, in debt. They would have a very hard time raising the capital needed to really monetize the tech. Instead of leasing out the tech, which involves capital to build the units, for peanuts compared to what it could produce, they could give exclusive rights to a proven fortune 500 executive like Morrison and share in some real money.
Once they have money coming in other than from another 12 million in the financing, which is what they stated in the 10-k they need for operations, they could be taking in revenue without any expense and continue to pursue other uses of the tech.
I just keep going back to Morrison. I don't see someone of his reputation getting involved in some penny anty BS. I think he sees something huge here.
CNGT!!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM